Pharmacovigilance Market 2020 Global Industry Trends, Size, Share Analysis to 2027 is latest report published on “Global Pharmacovigilance Market” by Fortune Business Insights. According to this report Global Pharmacovigilance Market will rise from Covid-19 crisis at moderate growth rate during 2020 to 2027. Report segments comprehensive information about Pharmacovigilance Market By Type (Service and Software), By Deployment (In-house and Outsource), By End User (Hospitals, Pharmaceutical Companies, and Others), and Regional Forecast, 2020-2027.
Some of the companies operating the industry are:
- ICON plc (Ireland)
- Bioclinica (U.S)
- Accenture plc (Ireland)
- Covance Inc. (U.S)
- Quanticate (U.S)
- Pharmaceutical Product Development, LLC (U. S)
- Cognizant (U.S)
- Parexel International Corporation (U.S)
- IQVIA (U.S)
Get Sample Copy of Global Pharmacovigilance Market Report
Pharmacovigilance Market Analysis From 2020 To 2027:
The global Pharmacovigilance market size is projected to reach USD 12.25 billion by 2027, exhibiting a CAGR of 12.3% during the forecast period. The coronavirus pandemic has claimed more than 200,000 lives worldwide and has afflicted around 3.5 million people in a span of a few months. While a vaccine for the infection is still many months away, biomedical organizations are currently focused on developing effective treatment options for COVID-19 to contain the contagion.
Pharmacovigilance Market includes comprehensive information derived from depth study on Pharmacovigilance Industry historical and forecast market data. Global Pharmacovigilance Market Size To Expand moderately as the new developments in Pharmacovigilance and Impact of COVID19 over the forecast period 2020 to 2027.
Major players in this market are exploring new avenues of innovation by developing automated PV solutions and tools to enable rapid assessment of new medication. Furthermore, established players such as IQVIA and Bayer are launching PV products to strengthen their market position, while new entrants are focusing on expanding their portfolio to build a solid customer base and establish their presence in the market. Lastly, the COVID-19 outbreak has created a vast plethora of opportunities for companies to leverage their capacities and provide professional services to end-users.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations travel bans and quarantines restaurants closed all indoor events restricted over forty countries state of emergency declared massive slowing of the IT Spending market volatility falling business confidence, growing panic among the population, and uncertainty about future.
Safety and efficacy are the two important parameters that a drug needs to pass through during each clinical trial phase. Nowadays, populations are more aware about the side effects of OTC medicines and thus demand safer medications. This is likely to boost this market value owing to surveillance of marketed medications for possible ADRs. Moreover, government initiatives and programs and pharmaceutical companies’ awareness campaigns are creating a greater impact in spreading reliable information about medicines, proper use of medicines, side-effects of medicines, and others. For example, Uppsala Monitoring Centre (UMC) every year conducts a social media campaign to promote patient and public awareness about the safe use of medicines as well as reporting of suspected ADRs. In 2019, UMC launched a campaign focusing on polypharmacy and safe use of medicines in the elderly population. Therefore, such positive initiatives are likely to foster growth and development of this market during the forecast period.
The Global Pharmacovigilance Market 2020 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Pharmacovigilance market report is provided for the international markets as well as development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report additionally states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market
Regional Market Overview:
On the geographical front, the global pharmacovigilance market is classified into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The market size in North America stood at USD 1.94 billion in 2019, marking its lead position. North America leads this market share, owing to the highest number of PV activities in the region. Coupled with this is the large number of deaths due to ADRs, resulting in the rigorous need for PV. Moreover, the region has well-established PV centers with advanced software in managing the activities. Europe accounts for the second position in the market owing to its focus on risk assessment of the medicinal products.
This report focuses on Pharmacovigilance Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2024, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
Competitive Analysis:
The Pharmacovigilance Market Size, Share, Growth report examines competitive scenario by analyzing key players in the market. The company profiling of leading market players is included this report with Porter’s five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.
Key questions answered in the report:
- What will the market growth rate of Pharmacovigilance market in 2027?
- What are the key factors driving the global Pharmacovigilance market?
- Who are the key manufacturers in Pharmacovigilance market space?
- What are the market opportunities, market risk and market overview of the Pharmacovigilance market?
- What are sales, revenue, and price analysis of top manufacturers of Pharmacovigilance market?
- Who are the distributors, traders and dealers of Pharmacovigilance market?
- What are the Pharmacovigilance market opportunities and threats faced by the vendors in the global Pharmacovigilance industry?
- What are sales, revenue, and price analysis by types and applications of Pharmacovigilance market?
- What are sales, revenue, and price analysis by regions of Pharmacovigilance industry?
Table Of Content:
1 Market Overview
1.1 Pharmacovigilance Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
3 Global Pharmacovigilance Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Pharmacovigilance Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Pharmacovigilance Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Pharmacovigilance Manufacturer Market Share in 2018
3.3.2 Top 6 Pharmacovigilance Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Pharmacovigilance Market Analysis by Regions
4.1 Global Pharmacovigilance Sales, Revenue and Market Share by Regions
4.1.1 Global Pharmacovigilance Sales and Market Share by Regions (2014-2019)
4.1.2 Global Pharmacovigilance Revenue and Market Share by Regions (2014-2019)
4.2 North America Pharmacovigilance Sales and Growth Rate (2014-2019)
4.3 Europe Pharmacovigilance Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Pharmacovigilance Sales and Growth Rate (2014-2019)
4.5 South America Pharmacovigilance Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Pharmacovigilance Sales and Growth Rate (2014-2019)
5 North America Pharmacovigilance by Country
5.1 North America Pharmacovigilance Sales, Revenue and Market Share by Country
5.1.1 North America Pharmacovigilance Sales and Market Share by Country (2014-2019)
5.1.2 North America Pharmacovigilance Revenue and Market Share by Country (2014-2019)
5.2 United States Pharmacovigilance Sales and Growth Rate (2014-2019)
5.3 Canada Pharmacovigilance Sales and Growth Rate (2014-2019)
5.4 Mexico Pharmacovigilance Sales and Growth Rate (2014-2019)
8 South America Pharmacovigilance by Country
8.1 South America Pharmacovigilance Sales, Revenue and Market Share by Country
8.1.1 South America Pharmacovigilance Sales and Market Share by Country (2014-2019)
8.1.2 South America Pharmacovigilance Revenue and Market Share by Country (2014-2019)
8.2 Brazil Pharmacovigilance Sales and Growth Rate (2014-2019)
8.3 Argentina Pharmacovigilance Sales and Growth Rate (2014-2019)
8.4 Colombia Pharmacovigilance Sales and Growth Rate (2014-2019)
9 Middle East and Africa Pharmacovigilance by Countries
9.1 Middle East and Africa Pharmacovigilance Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Pharmacovigilance Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Pharmacovigilance Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Pharmacovigilance Sales and Growth Rate (2014-2019)
9.3 Turkey Pharmacovigilance Sales and Growth Rate (2014-2019)
9.4 Egypt Pharmacovigilance Sales and Growth Rate (2014-2019)
9.5 Nigeria Pharmacovigilance Sales and Growth Rate (2014-2019)
10 Pharmacovigilance Market In Developing Conutries
11 South America Pharmacovigilance Market Analysis by Countries
12 Competitive Landscape
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Pharmacovigilance Market Forecast
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
Continued…
Related News:
Clinical Decision Support Systems Market
Hairy Cell Leukemia Therapeutics Market
Artificial Tendons and Ligaments Market
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
